高级检索
当前位置: 首页 > 详情页

Optimal Colonoscopic Surveillance Interval After Normal Baseline Screening Colonoscopy

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ SSCI

机构: [1]The First Department of Medical Oncology, The Third Affiliated Hospital of Kunming Medical University, Tumor Hospital of Yunnan Province, Kunming, China. [2]Department of Otorhinolaryngology, The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine,Kunming, China. [3]Department of Gastroenterology, Yunnan Institute of Digestive Disease, The First Affiliated Hospital of Kunming Medical University, Kunming, China. [4]Department of Gastroenterology, The First People’s Hospital of Bijie City, Bijie, China.
出处:
ISSN:

摘要:
The optimal colonoscopic surveillance interval in the Chinese population is unclear. The present study aimed to assess the optimal colonoscopic surveillance interval after normal baseline screening colonoscopy to avoid overuse or underuse of colonoscopy. This retrospective study included individuals with normal baseline colonoscopy who had undergone at least 2 follow-up colonoscopy examinations at the Digestive Endoscopy Center of our hospital between 2000 and 2013. The risk factors for adenoma and the optimal colonoscopic surveillance interval were assessed. A total of 1,005 individuals (419 men; mean age, 49.34 ± 13.29 years) were included in the study. Of these, 169 individuals had adenomas at colonoscopic surveillance (mean, 1.32 ± 0.79 procedures). The mean adenoma diameter was 0.54 ± 0.38 cm, and the mean number of adenomas was 1.76 ± 1.29. The mean adenoma surveillance interval was 4.76 ± 2.89 years. The risk factors for adenoma identification were age more than 50 years and male gender. The optimal colonoscopic surveillance interval was 4.76 years according to an adenoma detection rate of 5%. The optimal colonoscopic surveillance interval is around 5 years for individuals with normal baseline colonoscopy. Age more than 50 years and male gender are risk factors for adenoma identification.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 胃肠肝病学 4 区 护理
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 胃肠肝病学 4 区 护理
JCR分区:
出版当年[2019]版:
Q4 GASTROENTEROLOGY & HEPATOLOGY Q4 NURSING
最新[2023]版:
Q4 NURSING Q4 GASTROENTEROLOGY & HEPATOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]The First Department of Medical Oncology, The Third Affiliated Hospital of Kunming Medical University, Tumor Hospital of Yunnan Province, Kunming, China.
通讯作者:
通讯机构: [3]Department of Gastroenterology, Yunnan Institute of Digestive Disease, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82494 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号